🟢 Arcturus Therapeutics is trading 10.28% up amid broader market gains

Arcturus Therapeutics is trading 10.28% higher at $14.37, with the gain appearing consistent with broader risk-on sentiment.

• The S&P 500 is up 0.70% and the Nasdaq Composite is up 1.04%, which may be supporting the move.
• No fresh company-specific announcement was identified for October 5. The latest listed release, dated September 23, covered interim Phase 2 OTC-deficiency results and the LUNAR 2.0 platform.